Abstract

Minichromosome maintenance protein 10 (MCM10) is essential for eukaryotic DNA replication. Here, we describe compound heterozygous MCM10 variants in patients with distinctive, but overlapping, clinical phenotypes: natural killer (NK) cell deficiency (NKD) and restrictive cardiomyopathy (RCM) with hypoplasia of the spleen and thymus. To understand the mechanism of MCM10-associated disease, we modeled these variants in human cell lines. MCM10 deficiency causes chronic replication stress that reduces cell viability due to increased genomic instability and telomere erosion. Our data suggest that loss of MCM10 function constrains telomerase activity by accumulating abnormal replication fork structures enriched with single-stranded DNA. Terminally-arrested replication forks in MCM10-deficient cells require endonucleolytic processing by MUS81, as MCM10:MUS81 double mutants display decreased viability and accelerated telomere shortening. We propose that these bi-allelic variants in MCM10 predispose specific cardiac and immune cell lineages to prematurely arrest during differentiation, causing the clinical phenotypes observed in both NKD and RCM patients.

Minichromosome maintenance protein 10 (MCM10) is critical for eukaryotic DNA replication. Here, by modelling MCM10 variants in human cell lines, the authors reveal a mechanism of MCM10-associated disease, finding that loss of MCM10 function constrains telomerase activity.

Details

Title
Bi-allelic MCM10 variants associated with immune dysfunction and cardiomyopathy cause telomere shortening
Author
Baxley, Ryan M 1   VIAFID ORCID Logo  ; Leung, Wendy 1 ; Schmit, Megan M 1   VIAFID ORCID Logo  ; Matson, Jacob Peter 2   VIAFID ORCID Logo  ; Yin Lulu 1 ; Oram, Marissa K 1   VIAFID ORCID Logo  ; Wang Liangjun 1 ; Taylor, John 3 ; Hedberg, Jack 1 ; Rogers, Colette B 1 ; Harvey, Adam J 1 ; Basu Debashree 1 ; Taylor, Jenny C 4 ; Pagnamenta Alistair T 4   VIAFID ORCID Logo  ; Dreau Helene 5 ; Craft, Jude 6 ; Ormondroyd, Elizabeth 7   VIAFID ORCID Logo  ; Watkins, Hugh 7   VIAFID ORCID Logo  ; Hendrickson, Eric A 1   VIAFID ORCID Logo  ; Mace, Emily M 8   VIAFID ORCID Logo  ; Orange, Jordan S 8 ; Aihara Hideki 1   VIAFID ORCID Logo  ; Stewart, Grant S 9   VIAFID ORCID Logo  ; Blair, Edward 6 ; Cook, Jeanette Gowen 2   VIAFID ORCID Logo  ; Bielinsky Anja-Katrin 1   VIAFID ORCID Logo 

 University of Minnesota, Department of Biochemistry, Molecular Biology, and Biophysics, Minneapolis, USA (GRID:grid.17635.36) (ISNI:0000000419368657) 
 University of North Carolina, Department of Biochemistry and Biophysics, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720) 
 Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Oxford, UK (GRID:grid.410556.3) (ISNI:0000 0001 0440 1440) 
 University of Oxford, Wellcome Centre Human Genetics, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Oxford NIHR Biomedical Research Centre, Oxford, UK (GRID:grid.454382.c) 
 University of Oxford, Department of Haematology, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK (GRID:grid.410556.3) (ISNI:0000 0001 0440 1440) 
 University of Oxford, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 Columbia University, Vagelos College of Physicians and Surgeons, New York, USA (GRID:grid.21729.3f) (ISNI:0000000419368729) 
 University of Birmingham, Institute of Cancer and Genomic Sciences, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2500686622
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.